Literature DB >> 7119272

Variable hemodynamic response to sodium nitroprusside in hypertensive crisis.

G Domenighetti, C Perret.   

Abstract

Five patients, three males and two females, admitted with severe hypertensive crisis underwent hemodynamic investigations before and during vasodilator therapy with sodium nitroprusside. In three hypervolemic patients with congestive heart failure and/or renal insufficiency, the drug induced a rapid fall in systemic arterial pressure and a beneficial effect on cardiac performance, as shown by a shift of the ventricular function curves to the left. In two hypovolemic patients, the hemodynamic response was quite different; vasodilator therapy induced a confusing clinical picture characterized by significant fluctuations in blood pressure, a severe fall in cardiac output and clinical signs of shock in spite of normal blood pressure. Hemodynamic response to vasodilator therapy with sodium nitroprusside in hypertensive crisis appears to be directly related to the circulating blood volume. The syndrome of hypertension associated with hypovolemia needs to be recognized promptly in order to avoid inappropriate therapy; in such cases volume expansion under precise hemodynamic monitoring appears to be an effective means of stabilizing the cardiocirculatory conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119272     DOI: 10.1007/bf01725736

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension.

Authors:  D I Graham
Journal:  Br Med J       Date:  1975-12-27

2.  Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study.

Authors:  C l Perret; J P Gardaz; M Reynaert; F Grimbert; J F Enrico
Journal:  Br Heart J       Date:  1975-06

3.  Treatment of malignant hypertension with sodium nitroprusside.

Authors:  D J Ahearn; C E Grim
Journal:  Arch Intern Med       Date:  1974-02

4.  Editorial: Malignant hypertension.

Authors:  F A Finnerty
Journal:  Am Heart J       Date:  1974-09       Impact factor: 4.749

5.  Dependence of arterial pressure on intravascular volume in treated hypertensive patients.

Authors:  H P Dustan; R C Tarazi; E L Bravo
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

6.  The value of aggressive therapy in the hypertensive patient with azotemia.

Authors:  W J Mroczek; M Davidov; L Gavrilovich; F A Finnerty
Journal:  Circulation       Date:  1969-12       Impact factor: 29.690

Review 7.  [Treatment of the hypertensive crisis].

Authors:  C Perret; P Girardet
Journal:  Schweiz Med Wochenschr       Date:  1973-11-24

8.  Blindness after treatment for malignant hypertension.

Authors:  D H Cove; M Seddon; R F Fletcher; D C Dukes
Journal:  Br Med J       Date:  1979-07-28

9.  Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.

Authors:  R R Miller; L A Vismara; R Zelis; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

10.  Hypertensive encephalopathy: recognition and management.

Authors:  C V Ram
Journal:  Arch Intern Med       Date:  1978-12
View more
  2 in total

Review 1.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 2.  Perioperative hypertension management.

Authors:  Joseph Varon; Paul E Marik
Journal:  Vasc Health Risk Manag       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.